PT3016673T - Osteopontina de leite de mamífero para melhorar a resposta imunitária - Google Patents
Osteopontina de leite de mamífero para melhorar a resposta imunitáriaInfo
- Publication number
- PT3016673T PT3016673T PT147359640T PT14735964T PT3016673T PT 3016673 T PT3016673 T PT 3016673T PT 147359640 T PT147359640 T PT 147359640T PT 14735964 T PT14735964 T PT 14735964T PT 3016673 T PT3016673 T PT 3016673T
- Authority
- PT
- Portugal
- Prior art keywords
- osteopontinine
- immune response
- mammalian milk
- improve immune
- improve
- Prior art date
Links
- 230000028993 immune response Effects 0.000 title 1
- 239000008267 milk Substances 0.000 title 1
- 210000004080 milk Anatomy 0.000 title 1
- 235000013336 milk Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Marine Sciences & Fisheries (AREA)
- Dispersion Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361843185P | 2013-07-05 | 2013-07-05 | |
| EP13175267 | 2013-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3016673T true PT3016673T (pt) | 2018-01-30 |
Family
ID=48740972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT147359640T PT3016673T (pt) | 2013-07-05 | 2014-07-04 | Osteopontina de leite de mamífero para melhorar a resposta imunitária |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US9956283B2 (enExample) |
| EP (1) | EP3016673B1 (enExample) |
| JP (1) | JP6509833B2 (enExample) |
| KR (1) | KR102307002B1 (enExample) |
| CN (1) | CN105407910B (enExample) |
| AU (1) | AU2014286123B2 (enExample) |
| BR (1) | BR112016000067B1 (enExample) |
| CA (1) | CA2916821C (enExample) |
| CL (1) | CL2015003803A1 (enExample) |
| DK (1) | DK3016673T3 (enExample) |
| EA (1) | EA034654B1 (enExample) |
| ES (1) | ES2656474T3 (enExample) |
| MX (1) | MX369925B (enExample) |
| NZ (1) | NZ715430A (enExample) |
| PH (1) | PH12015502844B1 (enExample) |
| PL (1) | PL3016673T3 (enExample) |
| PT (1) | PT3016673T (enExample) |
| WO (1) | WO2015001092A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102967831B1 (ko) * | 2018-04-25 | 2026-05-20 | 헬쓰 앤드 해피니스 (에이치＆에이치) 홍콩 리미티드 | 의약으로 사용하기 위한 오스테오폰틴 및 2'-푸코실락토오스의 조합물 |
| US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
| CN113424962A (zh) * | 2020-09-21 | 2021-09-24 | 黑龙江飞鹤乳业有限公司 | 提高免疫力的营养组分、含有其的食品或保健品及其用途 |
| EP4326758A4 (en) * | 2021-04-20 | 2025-03-19 | University of Cincinnati | A vaccine adjuvant for infectious diseases |
| CN113475720B (zh) * | 2021-06-15 | 2023-07-25 | 合生元（广州）健康产品有限公司 | 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用 |
| EP4472656A1 (en) * | 2022-01-31 | 2024-12-11 | Société des Produits Nestlé S.A. | Compositions comprising osteopontin (opn) |
| CN117337994A (zh) * | 2023-10-11 | 2024-01-05 | 黑龙江飞鹤乳业有限公司 | 功能性组合物及该组合物的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998056405A1 (en) | 1997-06-10 | 1998-12-17 | Whitehead Institute For Biomedical Research | A method of modulating immune response with osteopontin |
| CA2293492A1 (en) * | 1997-06-11 | 1998-12-17 | Martin Berry | Cns neuroregenerative compositions and methods of use |
| CA2370129A1 (en) | 1999-04-15 | 2000-10-26 | Children's Medical Center Corporation | Methods and compositions for modulating an immune response |
| US7259243B2 (en) | 2000-01-07 | 2007-08-21 | Arla Foods Amba | Process for isolation of osteopontin from milk |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| AU2003239589A1 (en) * | 2002-05-24 | 2003-12-12 | Schering-Plough Ltd. | Eta-1 gene and methods for use |
| ES2444843T3 (es) * | 2003-09-18 | 2014-02-27 | Arla Foods Amba | Fórmula para lactantes |
| EP1667537B1 (en) * | 2003-09-18 | 2013-11-06 | Arla Foods Amba | Infant formula |
| KR20090123115A (ko) | 2008-05-27 | 2009-12-02 | 한국생명공학연구원 | 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법 |
| AU2012222312B2 (en) * | 2011-03-03 | 2017-06-08 | Arla Foods Amba | Method for isolating osteopontin using feeds containing cmp or casein species |
| US20150344534A1 (en) * | 2011-12-07 | 2015-12-03 | Arla Foods Amba | Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants |
-
2014
- 2014-07-04 MX MX2016000107A patent/MX369925B/es active IP Right Grant
- 2014-07-04 NZ NZ715430A patent/NZ715430A/en unknown
- 2014-07-04 CN CN201480038124.7A patent/CN105407910B/zh active Active
- 2014-07-04 EP EP14735964.0A patent/EP3016673B1/en active Active
- 2014-07-04 US US14/903,049 patent/US9956283B2/en active Active
- 2014-07-04 BR BR112016000067-6A patent/BR112016000067B1/pt active IP Right Grant
- 2014-07-04 EA EA201690057A patent/EA034654B1/ru not_active IP Right Cessation
- 2014-07-04 DK DK14735964.0T patent/DK3016673T3/da active
- 2014-07-04 KR KR1020167002892A patent/KR102307002B1/ko active Active
- 2014-07-04 PT PT147359640T patent/PT3016673T/pt unknown
- 2014-07-04 ES ES14735964.0T patent/ES2656474T3/es active Active
- 2014-07-04 AU AU2014286123A patent/AU2014286123B2/en active Active
- 2014-07-04 WO PCT/EP2014/064339 patent/WO2015001092A1/en not_active Ceased
- 2014-07-04 JP JP2016522645A patent/JP6509833B2/ja active Active
- 2014-07-04 CA CA2916821A patent/CA2916821C/en active Active
- 2014-07-04 PL PL14735964T patent/PL3016673T3/pl unknown
-
2015
- 2015-12-21 PH PH12015502844A patent/PH12015502844B1/en unknown
- 2015-12-31 CL CL2015003803A patent/CL2015003803A1/es unknown
-
2018
- 2018-04-04 US US15/945,517 patent/US10772955B2/en not_active Ceased
-
2022
- 2022-01-12 US US17/573,707 patent/USRE50281E1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CL2015003803A1 (es) | 2016-08-05 |
| US10772955B2 (en) | 2020-09-15 |
| CN105407910A (zh) | 2016-03-16 |
| AU2014286123B2 (en) | 2019-02-28 |
| MX369925B (es) | 2019-11-25 |
| NZ715430A (en) | 2022-01-28 |
| CA2916821C (en) | 2023-10-03 |
| BR112016000067A2 (enExample) | 2017-09-05 |
| EA034654B1 (ru) | 2020-03-03 |
| EP3016673A1 (en) | 2016-05-11 |
| USRE50281E1 (en) | 2025-01-28 |
| KR102307002B1 (ko) | 2021-10-05 |
| EA201690057A1 (ru) | 2016-07-29 |
| US20160136268A1 (en) | 2016-05-19 |
| DK3016673T3 (da) | 2018-01-29 |
| CA2916821A1 (en) | 2015-01-08 |
| MX2016000107A (es) | 2016-06-07 |
| CN105407910B (zh) | 2019-12-03 |
| KR20160030960A (ko) | 2016-03-21 |
| ES2656474T3 (es) | 2018-02-27 |
| BR112016000067B1 (pt) | 2022-08-30 |
| AU2014286123A1 (en) | 2016-01-21 |
| JP2016529217A (ja) | 2016-09-23 |
| JP6509833B2 (ja) | 2019-05-08 |
| PL3016673T3 (pl) | 2018-04-30 |
| PH12015502844A1 (en) | 2016-03-28 |
| US9956283B2 (en) | 2018-05-01 |
| WO2015001092A1 (en) | 2015-01-08 |
| PH12015502844B1 (en) | 2016-03-28 |
| US20180289798A1 (en) | 2018-10-11 |
| EP3016673B1 (en) | 2017-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR302014001231S1 (pt) | Configuração aplicada em torradeira. | |
| DK3015467T3 (da) | Morpholino-oligonukleotidfremstillingsfremgangsmåde | |
| BR302013003484S1 (pt) | Configuração aplicada a umidificador | |
| PT3038690T (pt) | Bolsa destinada a recolher urinas | |
| EP2962276A4 (en) | STIMULATED DIVISION OF PHOTOS | |
| BR302013003730S1 (pt) | Configuração aplicada em tigela | |
| DK3234476T3 (da) | Solfanger | |
| EP2948008A4 (en) | BRA | |
| BR112015023736A2 (pt) | método para manufaturar dispositivo fotovoltaico | |
| EP2964517A4 (en) | ROWING | |
| EP3027056C0 (en) | COMPOSITION TO IMPROVE IMMUNITY | |
| HUE050917T2 (hu) | Hidrokortizon-tartalmú készítmény | |
| BR302013005375S1 (pt) | Configuração aplicada em copo dosador | |
| HUE036203T2 (hu) | Spiro-oxazolonok | |
| EP2923944A4 (en) | ornithopter | |
| HUE046318T2 (hu) | Élelmiszer készítmény | |
| BR302013000505S1 (pt) | Configuração aplicada em aparelho coletor | |
| TH1401007006A (th) | วิธีผลิตกรดแลคติก | |
| BR302013003405S1 (pt) | Configuração aplicada em recipiente multi-alimentos | |
| BR302013000970S1 (pt) | Configuração aplicada em tigela | |
| BR302013004008S1 (pt) | Configuração aplicada a churrasqueira | |
| TH1501000010A (th) | วิธีผลิตสารละลายน้ำตาล | |
| TH1401007454A (th) | วิธีผลิตสารละลายน้ำตาล | |
| TH1401006881A (th) | วิธีผลิตสารละลายน้ำตาล | |
| BR302013002752S1 (pt) | Configuração aplicada em boneca |